Akero Therapeutics

Price & Volume

Stats

Open	$41.99
Previous Close	$42.17
Day Range	$41.36-$43.44
52W Range	$17.86-$58.40
Market Cap	$3.3B
Shares Short	6M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$3.75

News

Yahoo Finance • 7 days ago

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Akero Therapeutics, Inc. to Contact Law Firm

Yahoo Finance • last month

Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is Investigating Claims on Your Behalf

Yahoo Finance • 2 months ago

Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Yahoo Finance • 2 months ago

Is Akero Therapeutics Inc. (AKRO) the Best Performing Mid Cap Stock to Buy According to Analysts?

About

CEO	Dr. Andrew Cheng M.D., Ph.D.
CFO	Mr. William R. White J.D.
Address	601 Gateway Boulevard, South San Francisco, CA, United States, 94080
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	63